- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)
- 4 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
LBN.2: 12 residues within 4Å:- Chain A: L.953, D.970, V.973, I.974, V.977
- Chain B: C.1084, K.1085, T.1086, G.1087, W.1089, I.1090
- Ligands: 6OU.1
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:L.953, B:W.1089
- Hydrogen bonds: B:W.1089
LBN.7: 12 residues within 4Å:- Chain B: L.953, D.970, V.973, I.974, V.977
- Chain C: C.1084, K.1085, T.1086, G.1087, W.1089, I.1090
- Ligands: 6OU.6
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:W.1089, B:L.953
- Hydrogen bonds: C:W.1089
LBN.12: 12 residues within 4Å:- Chain C: L.953, D.970, V.973, I.974, V.977
- Chain D: C.1084, K.1085, T.1086, G.1087, W.1089, I.1090
- Ligands: 6OU.11
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:L.953, D:W.1089
- Hydrogen bonds: D:W.1089
LBN.17: 12 residues within 4Å:- Chain A: C.1084, K.1085, T.1086, G.1087, W.1089, I.1090
- Chain D: L.953, D.970, V.973, I.974, V.977
- Ligands: 6OU.16
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:W.1089, D:L.953
- Hydrogen bonds: A:W.1089
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.3: 16 residues within 4Å:- Chain A: V.1014, M.1017, L.1018, L.1021, K.1044, F.1047, Y.1048, Y.1051, W.1052
- Chain B: D.1064, W.1089, P.1092, A.1093, A.1096, L.1100
- Ligands: PX2.5
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:V.1014, A:L.1018, A:F.1047, A:Y.1051
- Salt bridges: A:K.1044, A:K.1044
Y01.4: 14 residues within 4Å:- Chain A: M.1022, P.1038, S.1039, W.1040, L.1042, A.1043, I.1046
- Chain D: I.883, L.886, M.887, N.890, Y.891, L.894, Y.983
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain A- Hydrophobic interactions: D:Y.891, A:W.1040
Y01.8: 16 residues within 4Å:- Chain B: V.1014, M.1017, L.1018, L.1021, K.1044, F.1047, Y.1048, Y.1051, W.1052
- Chain C: D.1064, W.1089, P.1092, A.1093, A.1096, L.1100
- Ligands: PX2.10
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:V.1014, B:L.1018, B:F.1047, B:Y.1051
- Salt bridges: B:K.1044, B:K.1044
Y01.9: 14 residues within 4Å:- Chain A: I.883, L.886, M.887, N.890, Y.891, L.894, Y.983
- Chain B: M.1022, P.1038, S.1039, W.1040, L.1042, A.1043, I.1046
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:W.1040, A:Y.891
Y01.13: 16 residues within 4Å:- Chain C: V.1014, M.1017, L.1018, L.1021, K.1044, F.1047, Y.1048, Y.1051, W.1052
- Chain D: D.1064, W.1089, P.1092, A.1093, A.1096, L.1100
- Ligands: PX2.15
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:V.1014, C:L.1018, C:F.1047, C:Y.1051
- Salt bridges: C:K.1044, C:K.1044
Y01.14: 14 residues within 4Å:- Chain B: I.883, L.886, M.887, N.890, Y.891, L.894, Y.983
- Chain C: M.1022, P.1038, S.1039, W.1040, L.1042, A.1043, I.1046
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:W.1040, B:Y.891
Y01.18: 16 residues within 4Å:- Chain A: D.1064, W.1089, P.1092, A.1093, A.1096, L.1100
- Chain D: V.1014, M.1017, L.1018, L.1021, K.1044, F.1047, Y.1048, Y.1051, W.1052
- Ligands: PX2.20
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:V.1014, D:L.1018, D:F.1047, D:Y.1051
- Salt bridges: D:K.1044, D:K.1044
Y01.19: 14 residues within 4Å:- Chain C: I.883, L.886, M.887, N.890, Y.891, L.894, Y.983
- Chain D: M.1022, P.1038, S.1039, W.1040, L.1042, A.1043, I.1046
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:W.1040, C:Y.891
- 4 x PX2: 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHATE(Non-covalent)
PX2.5: 7 residues within 4Å:- Chain A: L.1018, W.1040, K.1041, A.1043, K.1044, F.1047
- Ligands: Y01.3
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.1044
PX2.10: 7 residues within 4Å:- Chain B: L.1018, W.1040, K.1041, A.1043, K.1044, F.1047
- Ligands: Y01.8
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.1044
PX2.15: 7 residues within 4Å:- Chain C: L.1018, W.1040, K.1041, A.1043, K.1044, F.1047
- Ligands: Y01.13
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:K.1044
PX2.20: 7 residues within 4Å:- Chain D: L.1018, W.1040, K.1041, A.1043, K.1044, F.1047
- Ligands: Y01.18
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:K.1044
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yin, Y. et al., Molecular basis of neurosteroid and anticonvulsant regulation of TRPM3. Nat.Struct.Mol.Biol. (2025)
- Release Date
- 2025-01-22
- Peptides
- Transient receptor potential cation channel, subfamily M, member 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)
- 4 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x PX2: 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yin, Y. et al., Molecular basis of neurosteroid and anticonvulsant regulation of TRPM3. Nat.Struct.Mol.Biol. (2025)
- Release Date
- 2025-01-22
- Peptides
- Transient receptor potential cation channel, subfamily M, member 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.